• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/15

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

15 Cards in this Set

  • Front
  • Back
Halothane (Flouthane)- MAC & BGC
0.75%
2.4
Nitrous Oxide - MAC & BGC
104%
0.47
Desflurane (Suprane) - MAC & BGC
6%
0.42
Isoflurane (Forane)- MAC & BGC
1.2%
1.4
Enflurane - MAC & BGC
1.63%
1.91
Sevoflurane (Ultane)
2%
o.65
Factors Affecting Inspiratory Concentration(Fi) of VA
FGF (flow rate) (increase FGF --> increase Fi);
Breathing system volume;
Machine “absorption” of agent.
The three factors that determine the transfer of anesthetics from blood to tissue
Tissue solubility;
Tissue blood flow;
The difference between partial pressure arterial blood and tissue.
Factors which influence the rate of uptake
Inspired concentration
Minute ventilation
Cardiac output
Alveolar-venous concentration difference;
Solubility.
These factors speed induction & elimination:
Increased FGF
Increased ventilation
High CBF (cerebral blood flow)
Elimination of agent is from the: VR > M > F > VP
Anesthesia depth can be assessed by:
Lack of movement in non-paralyzed state
Respiration rate and pattern
Respiratory depression (ET CO2 and VE )
Eye signs
BP and P less valuable
BIS and Entropy analysis
Inhalation agents -
Degree of Biotransformation:
Halothane > sevoflurane > isoflurane > desflurane
Respiratory Effects of VA
Abolish the hypoxic response at less than half MAC concentrations;
Bronchodilators by direct action on smooth muscle.
CV effects of VA
Isoflurane and desflurane cause inc HR which may mask depression;
Isoflurane and desflurane decrease SVR while Halothane and NO do not change it.
Systemic effects of NO
CV: Sympathomimetic. May decrease myocardial contractility BUT increases overall CV function. Induced catecholamines and may cause arrhythmias.
Respiratory: Tachypnea/dec TV but no change in MV and PaCO2. Inhibited hypoxic drive (periph chemo receptors to low PaO2). Increases PVR.
Cerebral: Increases CBF/CBV, mild inc in ICP.
Neurmuscular: No effect, but augments MR
Renal: Dec BF & Dec GFR.
Hepatic: Mild dec BF.
GI: Increases N/V (?) due to solubility
Metabolism: Exhaled. May inhibit Vit B12 (important with pregnant woman b/c in 1st trimester is when the neuro tube is developing, it may alter this)